Electrocore Inc is a medical technology company focused on developing non-invasive neuromodulation therapies to treat various conditions, particularly those related to the central nervous system
The company specializes in innovative solutions that utilize electrical stimulation to modulate nerve activity, aiming to address ailments such as migraines, cluster headaches, and other chronic pain conditions. By leveraging its proprietary technology, Electrocore seeks to provide patients with alternative treatment options that can enhance their quality of life while minimizing reliance on traditional pharmaceuticals. The company's commitment to research and development underscores its goal of advancing neuromodulation as a viable therapeutic approach in the healthcare landscape.
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.
In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain management and perfor
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
